Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease

Gastroenterology

Volumn 119, Issue 6, 2000, Pages 1461-1472

  Schreiber, Stefan ^a   Fedorak, Richard N ^a   Nielsen, Ole Haagen ^a   Wild, Gary ^a   Williams, C Noel ^a   Nikolaus, Susanna ^a   Jacyna, Meron ^a   Lashner, Bret A ^a   Gangl, Alfred ^a   Rutgeerts, Paul ^a   Isaacs, Kim ^a   Van Deventer, Sander J H ^a   Koningsberger, Jacob C ^a   Cohard, Marielle ^a   LeBeaut, Alesandre ^a   Hanauer, Stephen B ^a  

^a HUMBOLDT STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; PLACEBO; RECOMBINANT INTERLEUKIN 10;

ADULT; ARTICLE; CLINICAL TRIAL; COLONOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROHN DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REMISSION; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; VERTIGO;

EID: 0034464148     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2000.20196     Document Type: Article

References (42)

1. Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease
2. Tumour necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine
3. Tumor necrosis factor-α, interleukin-1β and interleukin 6 expression in inflammatory bowel disease
4. Cytokine mRNA profiles in inflammatory bowel disease mucosa detected by PCR amplification
5. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
6. National cooperative Crohn's disease study: Results of drug treatment
7. European cooperative Crohn's disease study (ECCDS): Results of drug treatment
8. Development and validation of an endoscopic index of the severity for Crohn's disease: A prospective, multicentre study
9. Interleukin 10
10. Two types of mouse T helper cells. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
11. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration
12. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease
13. IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: A new therapeutic approach
14. IL-10 as a therapeutic strategy in the treatment of rheumatoid arthritis
15. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
16. Activation of nuclear factor kappa B in inflammatory bowel disease
17. The NF-KB and I-KB proteins: New discoveries and insights
18. Role of transcriptional activation by IkB in mediation of immunosuppression by glucocorticoids
19. Immunosuppression by glucocorticoids: Inhibition of NFkB activity through induction of IkB synthesis
20. Interleukin-10-deficient mice develop chronic enterocolitis
21. Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease
22. Multiple doses of intravenous interleukin 10 in patients with inflammatory bowel disease
23. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor α for Crohn's disease
24. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study
25. An interleukin-4-induced transcription factor: IL-4 stat
26. Tumor necrosis factor and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kb
27. Mechanisms in failure of infliximab in Crohn's disease
28. Appearance of nuclear protease after embryonal carcicomal cells undergo differentiation
29. The overlapping octamer/TAATGARAT motif is a high-affinity binding site for the cellular transcription factors Oct-1 and Oct-2
30. Effect of leupeptin on the autophagic vacuolar system of rat hepatocyes. Correlation between ultrastructure and degradation of membrane and cytosolic proteins
31. Protein measurements with the Folin phenol reagent
32. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
33. A new measure of health status for clinical trials in inflammatory bowel disease
34. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
35. Randomised controlled trial of CDP571 antibody to tumour necrosis factor-alpha in Crohn's disease
36. Genetics of inflammatory bowel disease
37. Genetics and inflammatory bowel disease
38. Interleukin-10 as a regulatory cytokine induced by cellular stress: Molecular aspects
39. Anti- and pro-inflammatory effects of interleukin-10 in mild to moderate Crohn's disease
40. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding